Portfolio company
TURN BIO
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops mRNA-based medicines to rejuvenate cells and treat age-related conditions for patients with dermatological, immunological, and osteoarthritic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Turn Biotechnologies
This company develops mRNA medicines and delivery platforms for cellular rejuvenation and tissue repair to treat age-related conditions for patients and pharmaceutical partners.
Rejuvenation Technologies
This company develops mRNA-based telomere extension therapies to treat patients with pulmonary fibrosis, liver disease, and other age-related conditions.
RejuverSen
This biotechnology firm develops senolytic therapies to eliminate senescent cells for treating cancer, fibrosis and age-related diseases in humans.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
Altos Labs
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
NewLimit
This biotechnology company develops epigenetic reprogramming medicines to restore cellular function and treat age-related diseases for patients.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Rubedo.Life
This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.
